Literature DB >> 23218120

Is the intravenous supplementation of amino acid to cancer patients adequate? A critical appraisal of literature.

Federico Bozzetti1, Valentina Bozzetti.   

Abstract

BACKGROUND & AIMS: International guidelines are quite vague regarding the optimal doses of amino acid to administer to cancer patients and standard practice appears not to be supported by specific investigations. The purpose of this study is to determine from the literature whether there are some correlates among amino acid infusions and nutritional-metabolic or clinical outcomes.
METHODS: Through the help of PubMed (www.ncbi.nlm.nih.gov) and the use of a personal database we analysed papers reporting details of infused amino acid and metabolic-nutritional or clinical effects.
RESULTS: Five short-term metabolic studies using isotopes showed that infusion of about 2 g amino acid/kg/day (including high doses of branched chain amino acid) positively affects protein metabolism of severely malnourished cancer patients. In eight studies in less malnourished patients receiving longer periods of parenteral nutrition, to allow the administration of oncologic therapy or to compensate for a decline in oral alimentation, the intravenous addition of 1.5 g amino acid/kg/day to the oral diet achieved positive results. These findings are concordant with recent metabolic results achieved in cancer patients receiving amino acid orally.
CONCLUSION: We think that a higher quantity of parenteral amino acids than that usually administered might be useful to cancer patients and further studies on this issue are warranted.
Copyright © 2012 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23218120     DOI: 10.1016/j.clnu.2012.10.017

Source DB:  PubMed          Journal:  Clin Nutr        ISSN: 0261-5614            Impact factor:   7.324


  7 in total

Review 1.  Nutritional and Exercise Interventions in Cancer-Related Cachexia: An Extensive Narrative Review.

Authors:  Vicente Javier Clemente-Suárez; Laura Redondo-Flórez; Alejandro Rubio-Zarapuz; Ismael Martínez-Guardado; Eduardo Navarro-Jiménez; José Francisco Tornero-Aguilera
Journal:  Int J Environ Res Public Health       Date:  2022-04-11       Impact factor: 4.614

Review 2.  Protein anabolic resistance in cancer: does it really exist?

Authors:  Mariëlle P K J Engelen; Barbara S van der Meij; Nicolaas E P Deutz
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2016-01       Impact factor: 4.294

Review 3.  Cancer-induced muscle wasting: latest findings in prevention and treatment.

Authors:  Zaira Aversa; Paola Costelli; Maurizio Muscaritoli
Journal:  Ther Adv Med Oncol       Date:  2017-03-08       Impact factor: 8.168

Review 4.  Nutrition in Cancer Patients.

Authors:  Paula Ravasco
Journal:  J Clin Med       Date:  2019-08-14       Impact factor: 4.241

Review 5.  Nutrition interventions to treat low muscle mass in cancer.

Authors:  Carla M Prado; Sarah A Purcell; Alessandro Laviano
Journal:  J Cachexia Sarcopenia Muscle       Date:  2020-01-08       Impact factor: 12.910

6.  The association between weight stability and parenteral nutrition characteristics and survival in patients with colorectal cancer.

Authors:  Wenli Liu; Aiham Qdaisat; Eric Lee; Jason Yeung; Khanh Vu; Jun-Zhong Lin; Todd Canada; Shouhao Zhou; Lorenzo Cohen; Eduardo Bruera; Sai-Ching J Yeung
Journal:  Gastroenterol Rep (Oxf)       Date:  2019-06-17

Review 7.  The Role of Nutrition in Primary and Secondary Prevention of Cardiovascular Damage in Childhood Cancer Survivors.

Authors:  Fiorentina Guida; Riccardo Masetti; Laura Andreozzi; Daniele Zama; Marianna Fabi; Matteo Meli; Arcangelo Prete; Marcello Lanari
Journal:  Nutrients       Date:  2022-08-11       Impact factor: 6.706

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.